Maria - Pharmsp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2009-09-02
Share capital
200,000.00 PLN
Registered address
ul. Kinga C. Gillette 11, 94-406 Łódź, Poland
Electronic delivery address
AE:PL-50171-64266-FDHDG-22

Financials

Revenue history (in k)

Financial insight

  • Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.

Filing timeliness

Financial statements were filed on time, on average 64 days early.

  • 202508/06/2026
  • 202402/07/2025
  • 202323/06/2024
  • 202221/06/2023
  • 202108/04/2022
  • 202008/04/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 35%
Division · Retail trade2,378 / 9,913
Top 24%
City · Łódź848 / 8,065
Top 11%
Voivodeship · Łódzkie2,059 / 15,300
Top 13%
Country · Poland38,294 / 297,935
Top 13%

Results vs industry

Revenue
This companyUSD 4.10mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD -59.51kMedianUSD 20.70kAverageUSD 86.70k
Operating costs
This companyUSD 4.14mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 809.93kMedianUSD 543.65kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Maria - Pharm has been an NFZ healthcare provider since 2016. In 2026 it is performing 4 contracts with a total value of USD 621.29. All its contracts were worth USD 5.33k in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Pilot programmesśląskie2USD 621.29
Other services provided in pharmaciesśląskie2USD 0.00

Authorized Representatives

Rafał Emil Jarząbek – Vice President of the Management Board
Igor Jachorski – President of the Management Board
Paulina Świderek – Vice President of the Management Board

Manner of representation

The management board consists of at least two members. If a multi-member management board is appointed, two members of the management board acting jointly or one member of the management board acting together with a commercial proxy are authorised to make declarations of will on behalf of the company.

Ownership

OwnerSharesShare valueStake
480$12,965.9624%
1,520$41,058.8976%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2009-09-14.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$4,553
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$4,682
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$4,415

Competitors

Name
Fragalsp. z o.o.
Modrzewscysp. j.
Ms-Pharmsp. z o.o. + limited partnership
Farmjug Agsp. z o.o.
MagmaxS.A.
Adpharmasp. z o.o.
Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j.
Novopharm - Millersp. j.
Pikadasp. z o.o.
Awicennasp. j.

Change history

DateEvent
2022-09-28Address change
2022-09-28PKD change
2015-12-16Address change
2015-12-16Share capital increase
2015-12-16Name change

FAQ

Last updated: 2026-06-08